| Literature DB >> 28090136 |
Abstract
Given the assumption that all methods of exercise, e.g., endurance (ET), resistance (RT), or combination of both (E+R), can induce a beneficial effect size (ES) for changes in body composition and health status of individuals who are overfat. Thus the aim and purpose of this study is to evaluate the current body of knowledge to address the question as to the impact that the duration of exercise has on its relative effectiveness for inducing health and body compositional changes in individuals who are overfat to assist with developing periodized exercise protocols and establishing short and long term goals. A tiered meta-analysis of 92-studies and 200-exercise groupings were used for establishing pooled ES within and between groupings based on the increments of 4-week of duration and study designs of ≤8, 9-16, 17-23, 24-36, and ≥36 weeks. Analysis based on random-effect of response indicates a continuum of effectiveness within and between ET, RT and E+R based on duration. Where beneficial effectiveness is not indicated for any measures until after 8-weeks of continuous training with progressive effectiveness being noted in changes to cardiorespiratory fitness, inflammatory cytokines, and alteration of metabolic status from 12-weeks through 32-weeks of continuous training. Results indicate a greater ES for RT and E+R versus ET early in intervention that equalizes with longer durations. Supporting the use of RT and E+R within a periodized program. And secondarily, goals should be established first on performance gains and second body composition or health status modifications for the individual who is overfat.Entities:
Keywords: Exercise Duration; Fitness; Health Status; Obesity; Overfatness
Year: 2016 PMID: 28090136 PMCID: PMC5143767 DOI: 10.5604/20831862.1212974
Source DB: PubMed Journal: Biol Sport ISSN: 0860-021X Impact factor: 2.806
SUPPLEMENTAL FIG. 1Summary of the evaluation methods and search engine returns of studies leading to the inclusion and subsequent meta-analysis based on the PRISMA checklist.
Studies utilized for analysis of differences in effectiveness for eliciting alternations in measures of interest based on the duration of training and the modality of exercise.
| Study | Exercise & Duration of Intervention | Summary Description of Exercise | Measures of Interest for comparison | |||
|---|---|---|---|---|---|---|
| ≤ 8-weeks | ||||||
| Ahmadi | ET: 5x’s/wk for 4-wk | ET[ | Morph, Adip, T2DM | |||
| Ara [ | RT: 3x’s/wk for 6-wk | RT[ | Morph, Ob | |||
| Ballor [ | RT: 3x’s/wk for 8-wk | RT: 3x10-12 @ 10RM for: Chest Press, Leg Press, Lateral Pull-down, Arm Curl/Ext, Leg Curl/Ext, Calf Raise | Morph | |||
| Boudou [ | ET: 3x’s/wk for 8-wk | ET: 2-sessions continuous @ 45-min/session @ 75% VO2peak, 1-session interval @ 5x2-min @85% VO2peak, 3-min rest interval @ 50% VO2peak | Morph, Ob, Adip | |||
| Fisher [ | ET or RT: 3x’s/wk for 8-wk | ET[ | CRP, Il-6, TNF-a | |||
| Halle [ | ET: Daily for 4-wk | ET[ | Morph, Ob, Adip | |||
| Hallsworth [ | ET: 3x’s/wk for 8-wk | RT: 3 set of 8-exercise CRT @ unknown repetition for bicep curl, calf press, triceps press, chest press, hamstring curl, shoulder press, leg extension, lateral pull-down @ 50-70% 1RM (progressive) with unknown rest interval | Morph, T2DM | |||
| Hammer [ | ET: 5x’s/wk for 6-wk | ET | Morph, T2DM | |||
| Hansen | ET: 3x’s/wk for 8-wk | ET: 55-min/session @ 50%VO2peak on ergometer OR 40-min/session @ 75% VO2peak on ergometer with training equivalent energetics (1.3±0.05 MJ/session) | Morph, VO2, Met S | |||
| Hill [ | ET: Daily for 5-wk | ET[ | Morph | |||
| Ishii [ | ET: 5x’s/wk for 6-wk | ET[ | Morph, Ob, VO2 | |||
| Kanaley [ | RT: 3x’s/wk for 6-wk | RT: 3 sets x 8-12 reps @ 80% 1RM (progressive) for chest press, leg press, shoulder press, lateral pull-down, leg extension, leg curl, bicep curl, triceps press-down, abdominal exercise (3x15) | Morph, Ob | |||
| Kempen [ | ET: 3x’s/wk for 8-wk | ET[ | Morph | |||
| Lucotti [ | ET or E+R: 5x’s/wk for 4-wk | ET[ | Morph, Ob, Adip, CRP, TNF-α, SBP, DBP, VO2 | |||
| Maiorana [ | E+R: 3x’s/wk for 8-wk | E+R: CRT for RT @ 45 s of RT @ 55-65 % MVC (progressive) w/ 15 s rest between RT followed by 5-min ET @ 70-85 % PHR (progressive) intermittent to RT-exercises | Morph, Ob, Adip, VO2 | |||
| Ng [ | ET or RT: 2-3x’s/wk for 8-wks | ET & RT equated to 3.5 METs per session per exercise | Morph, SBP, DBP, VO2 | |||
| Oberbach [ | ET: 4x’s/wk for 4-wks | ET: 3-days: 60-min unknown intensity (20-min calisthenics/20-min steady state/20-min “power-training” & 1-day: 60-min swimming | Morph, Adip, OB, Il-6, CRP | |||
| Tokmakidis | E+R: 4x’s/wk | ET: 40-45 min/session treadmill @ 60-80% HRmax (progressive) | Morph, T2DM | |||
| Touvra [ | E+R: 4x’s/wk for 8-wk | ET: 30 min/session @ 70-80% HRmax
| Morph, CRP, TNF-α, Il-6 | |||
| 9-15 Weeks | ||||||
| Ahmadizad [ | ET or RT: 3x’s/wk for 12-wk | ET: 75–85% of MHR for 20-30-min (progressive), | Morph, Adip | |||
| Ballor [ | ET or RT: 3x’s/wk for 12-wk | ET: 50% VO2max x 20-60 min (progressive) | Morph, SBP, DBP, VO2 | |||
| Bouchard [ | RT: 3x’s/wk for 12-wk | RT[ | Morph | |||
| Bryner [ | ET: 4x’s/wk | ET[ | Morph | |||
| Bweir [ | RT: 3x’s/wk for 10-wk | ET: 20-30-min/session (progressive) @ 60-75% HRmax
| Morph, T2DM | |||
| Christiansen [ | ET: 3x’s/wk for 12-wk | ET[ | Morph, Ob, Adip, Il-6, TNF-α, SBP, DBP, VO2 | |||
| Donnelly [ | ET, RT, or E+R: 4x’s/wk for 12-wk | ET[ | Morph, VO2 | |||
| Donnelly [ | RT: 3x’s/wk for 12-wk | RT[ | Morph, VO2 | |||
| Giannopoulou [ | ET: 3x’s/wk for 14-wk | ET[ | Morph, VO2 | |||
| Hill [ | ET: 5x’s/wk for 12-wk | ET[ | Morph | |||
| Ho [ | ET, RT, or | ET[ | Morph, Ob, Adip, VO2 | |||
| Jorge [ | ET, RT, or E+R: 3x’s/wk for 12-wk | 60-min/session: ET: cycle @ LAT | Morph, Adip, CRP, TNF-α, SBP, DBP, VO2 | |||
| Jung [ | ET: 5x’s/wk for 12-wk | ET: 30-min/session @ >5.3 METs OR | Morph | |||
| Kadoglou [ | ET: 4x’s/wk for 12-wk | ET: 30-60 min/session (progressive) @ 60-75% HRmax (progressive) | Morph, SBP, DBP, VO2 | |||
| Kang [ | ET or E+R: 3x’s/wk for 12-wk | ET[ | Morph, Adip, CRP, VO2 | |||
| Kempf [ | ET: 7x’s/wk for 12-wk | ET: 30-min/session of WiiFit Plus program @ self-selected intensity | Morph | |||
| Kerksick [ | E+R: 3x’s/wk for 14-wk | E+R: @ HR of 60-80% MHR using CRT of 14 exercises either paired: | Morph | |||
| Klimcakova [ | RT: 3x’s/wk for 12-wk | RT[ | Morph, Ob, Adip, Il-6, TNF-a, CRP, SBP, DBP, VO2 | |||
| Kwon [ | RT: 3x’s/wk for 12-wk | RT: 3 sets x 10-15 reps (elastic resistance) @ 40-50% 1RM (equivalent) for bicep curl, triceps extension, upright row, shoulder press, chest press, squat/deadlift, hip flexion, leg flexion, leg extension | Morph, T2DM | |||
| Lee [ | ET: 5x’s/wk for 13-wk | ET: 60-min/session @ 60% VO2peak | Morph, VO2 | |||
| Moreira [ | ET: 3x’s/wk for 12-wks | ET: 20-60 min (progressive) @ 10% of Anaerobic Threshold | Morph | |||
| Poirier [ | ET: 3x’s/wk for 12-wk | ET: 30 to 60-min/session (progressive) @ 60% VO2peak | Morph, VO2 | |||
| Polak [ | ET: 5x’s/wk for 12-wk | ET: 45-min @ 50-65% VO2max (progressive) for 2x’s/wk group exercise class, 3x’s/wk cycle ergometer | Morph, Ob, Adip, Il-6, TNF-α, VO2 | |||
| Racette [ | ET: 3x’s/wk for 12-wk | ET[ | Morph | |||
| Schjerve [ | ET or RT: 3x’s/wk for 12-wk | ET: Intervals @ 10-min @ 50-60% MHR followed by 4 cycles of 4-min: 3-min ratio of 85-95% MHR then 50-60% MHR followed by 5-min @ 50-60% MHR, or 47-min @60-70% MHR | Morph, SBP, DBP, VO2 | |||
| Sigal | ET, RT, or E+R: 3x’s/wk for 12-wk | ET[ | Morph, T2DM | |||
| Trapp [ | ET: 3x’s/wk for 15-wks | ET: Interval cycle ergometer @ 8-sec sprint: 12-sec recover intervals progress from 5-min to 20-min total time or 10-40 min @ 60% VO2peak (progressive) | Morph, Ob, Adip, VO2 | |||
| Wycherley [ | ET: 4-5x’s/wk for 12-wk | ET[ | Morph, SBP, DBP, VO2 | |||
| 16-23 weeks | ||||||
| Cauza [ | RT or ET: 3x’s/wk for 16-wk | ET: 15-90 min/session (progressive @ 5-min/session per week after 4th week) @ 60% VO2max
| Morph, SBP, DBP, VO2 | |||
| Cuff [ | ET or E+R: 3x’s/wk for 16-wk | E+R: 75-min @ 60-75% HRR w/ RT@ 2x12 for Leg Press, Leg Curl, Hip Ext, Chest Press, Latissimus Pulldown @ unknown intensity or rest | Morph, VO2 | |||
| De Feyter [ | E+R: Unknown sessions/wk | ET: Interval @ 4-8 sets (progressive) x 30-sec or 60- sec (50-60% Wmax) | Morph, Adip, CRP, TNF-α, SBP, DBP, VO2 | |||
| Donnelly | ET: 5x’s/wk for 16-wk | ET: 20-45 min @ 60%-75% HRR for ≈2000 kcal/wk (400 kcal/session) | Morph, VO2 | |||
| Honkola [ | RT: 3x’s/wk for 20-wk | RT: 2-set x 12-15 rep CRT for 8-10 whole body exercise (unknown exercises) @unknown intensity w/ <60-sec rest | Morph, SBP, DBP | |||
| Ibanez [ | RT: 2-3x’s/wk for 16-wk | RT[ | Morph, Ob, Adip, Met S | |||
| Irving [ | ET: 3-5x’s/wk for 16-wk | ET: unknown time @ RPE of 10-12 equate to 300-400 kcal/session OR unknown time @ RPE of 15-17 to equate to 300-400 kcal/session | Morph, Ob, Adip, SBP, DBP, VO2 | |||
| Josse [ | E+R: 7x’s/wk | ET: 7x’s/wk @ total expenditure of 250 kcal unknown duration or intensity | Morph, Il-6, TNF-α | |||
| Layman [ | E+R: 5x’s/wk | ET[ | Morph, Ob, Adip | |||
| Marks [ | E+R or RT: 3x’s/wk for 20-wk | ET[ | Morph | |||
| Rice [ | ET: 5x’s/wk | ET[ | Morph, T2DM | |||
| Snel [ | ET: 5x’s/wk for 16-wk | ET[ | Morph, CRP, SBP, DBP, VO2 | |||
| Tjønna[ | ET: 3x’s/wk for 16-wk | Interval ET: 10-min @ 70% MHR followed by 4-cyles of 4-min: 3-min @ 90% MHR and 70% MHR, then 5-min @ 50-60% MHR | Morph, Adip, SBP, DBP, VO2 | |||
| Tokmakidis | E+R: 4x’s/wk | ET: 40-45 min/session treadmill @ 60-80% HRmax (progressive) | Morph, T2DM | |||
| Toledo [ | ET: 6x’s/wk for 20-wk | ET[ | Morph, VO2 | |||
| Wycherley [ | RT: 3x’s/wk for 16-wk | RT[ | Morph, CRP, SBP, DBP, VO2 | |||
| 24-36 weeks | ||||||
| Borg | ET: 3x’s/wk for 24-wk | ET[ | Morph, T2DM | |||
| Brochu [ | RT: 3x’s/wk for 24-wk | RT[ | Morph, CRP, SBP, DBP | |||
| Carr | ET: 3x’s/wk for 24-wk | ET[ | Morph, VO2 | |||
| Church [ | ET, RT, or E+R: 3x’s/wk for 36-wk | ET: 50-min/session @ 50-80% VO2max equated to 12 kcal/kg body mass per wk | Morph, T2DM | |||
| Dobrosielski [ | E+R: 3x’s/wk for 26-wk | ET: 45-min/session @ 60-90% HRmax
| Morph, SBP, DBP, VO2 | |||
| Dobrosielski[ | E+R: 3x’s/wk for 26-wk | ET: unspecified | Morph, VO2 | |||
| Donnelly | ET: 5x’s/wk for 36-wk | ET: 20-45 min @ 60%-75% HRR for 1st 24-wks then 55%-70% of HRM (progressive) for ≈2000 kcal/wk (400 kcal/session) | Morph, VO2 | |||
| Dunstan [ | RT: 3-4x’s/ wk for 24-wk | RT | Morph | |||
| Hansen | ET: 3x’s/wk for 24-wk | Equivalent energetics (1.3±0.05 MJ/session) | Morph, VO2 | |||
| Karstoft [ | ET: 5x’s/wk for 24-wk | ET @ equated energetic demand for 60-min/session @ 55% VO2peak, or Interval @ 3-min intervals for 60-min/ session @ 1:1 ratio of high (>70% VO2peak) and low (self-paced <70% VO2peak) | Morph, SBP, DBP, VO2 | |||
| Ryan [ | RT or E+R: 3x’s/wk for 24-wk | ET[ | Morph | |||
| Sigal | ET, RT, or E+R: 3x’s/wk for 24-wk | ET[ | Morph, T2DM | |||
| Volpe [ | ET: 3x’s/wk for 36-wk | ET[ | Morph, Ob, SBP, DBP, VO2 | |||
| Watkins [ | ET: 3-4x’s/ wk for 26-wk | ET[ | Morph, SBP, DBP, VO2 | |||
| >36 weeks | ||||||
| Albu [ | ET: Unknown for 52-wk | ET[ | Morph, T2DM | |||
| Anderssen [ | ET: 3x’s/wk for 52-wk | ET[ | Morph, Ob, Adip, VO2 | |||
| Balducci[ | ET or E+R: 2x’s/wk for 52-wk | Equal energetics for ET & E+R progressive | Morph, Ob, Adip, Il-6, TNF-α, CRP, SBP, DBP, VO2, T2DM | |||
| Balducci[ | E+R: 2x’s/ wk for 52-wk | E[ | Morph, CRP, SBP, DBP, VO2, T2DM | |||
| Balducci[ | E+R: 2-3x’s/ wk for 52-wk | E+R progressive | Morph, CRP, SBP, DBP, VO2, T2DM | |||
| Balducci+ [ | E+R: 2-3x’s/ wk for 52-wk | E+R progressive | Morph, CRP, SBP, DBP, VO2, T2DM | |||
| Borg | ET: 3x’s/wk for 40-wk | ET‡: 45 min @ 60-70% VO2max
| Morph, T2DM | |||
| Carr | ET: 3x’s/wk for 104-wk | ET[ | Morph, VO2, T2DM | |||
| Donnelly | ET: 5x’s/wk for 52-wk and 68-wk | ET: 20-45 min @ 60%-75% HRR for 1st 24-wks then 55%-70% of HRM (progressive) for ≈2000 kcal/wk (400 kcal/session) | Morph, VO2 | |||
| Hawkins [ | ET: 6x’s/wk for 52-wk | ET: 60 min/session @ 60-85% HRmax either on ergometer or via community walking | Morph, VO2 | |||
| Heufelder [ | E+R: 3x’s/wk for 52-wk | ET[ | Adip, CRP, SBP, DBP | |||
| Olson [ | RT: 2x’s/wk for 52-wk | RT: 3x8–10 @ 8-10RM (Progressive) for unknown exercises indicated as isotonic variable resistance machines and free weights targeting the following major muscle groups: quadriceps, hamstrings, gluteals, pectorals, latissimus dorsi, rhomboids, deltoids, biceps and triceps | Morph, Adip, Il-6, CRP, SBP, DBP, T2DM | |||
| Pritchard [ | ET: 5x’s/wk for 52-wk | ET: 30-45 min @ 65-75% HRM | Morph, T2DM | |||
| Rokling-Andersen [ | ET: 3x’s/wk for 52-wk | ET[ | Morph, Adip, CRP, TNF-α, Il-6 | |||
| Yavari [ | ET, RT, or E+R: 3x’s/wk for 52-wk | ET: 20-60 min/session (progressive) @ 60-70% HRmax (progressive) on treadmill or cyclergometer | Morph, SBP, DBP, VO2, T2DM | |||
Note: Morph indicates any measure of body morphology/composition (e.g., body mass, fat mass or fat-free mass) and T2DM (e.g., fasting levels of glucose, insulin or HbA1c); and D indicates a dietary component to the intervention. All other abbreviations are noted within the list of abbreviations and generally agreed upon abbreviations for hormones.
Indicates study has data for analysis at multiple time points.
Indicates some results mirror previous reports from author and only utilized once within a time period for analysis.
Indicates a hypocaloric, or diabetic/low carbohydrate, dietary intervention used in conjunction with exercise.
FIG. 1Indicated pooled ES and CI.95 for effective to elicit responses in measures of body morphology (fat mass) for the duration of training (indicated by @ and then number of weeks of training) based on exposure to stimulus of the various methods of exercise. Indication of a positive ES shows favor for the use of intervention, while negative ES shows favor toward not utilizing said intervention. ET indicated by ●, RT indicated by ♦, E+R indicated by ■, and All Ex indicated by ▲.
FIG. 5Indicated pooled ES and CI.95 for effectiveness to induce improvements in aerobic fitness, VO2max, based on the various training durations (indicated by @ and then number of weeks of training) of exercise. Indication of a positive ES shows favor for the use of intervention, while negative ES shows favor toward not utilizing said intervention. ET indicated by ●, RT indicated by ♦, E+R indicated by ■, and All Ex indicated by ▲.
SUPPLEMENTAL FIG. 2Indicated pooled ES and CI.95 for effective to elicit responses in measures of body morphology (fat-free mass) for the various training duration utilized (indicated by @ and then number of weeks of training) for the exercise stimuli. Indication of a positive ES shows favor for the use of intervention, while negative ES shows favor toward not utilizing said intervention. ET indicated by ●, RT indicated by ♦, E+R indicated by ■, and All Ex indicated by ▲.
SUPPLEMENTAL FIG. 4Indicated pooled ES and CI.95 for effectiveness to elicit responses in measures of cardiovascular function, systolic (SBP) and diastolic (DBP) blood pressures, obtained based on the various training durations (indicated by @ and then number of weeks of training) for the stimulus of exercise. Indication of a positive ES shows favor for the use of intervention, while negative ES shows favor toward not utilizing said intervention. ET indicated by ●, RT indicated by ♦, E+R indicated by ■, and All Ex indicated by ▲.
Summary of the effectiveness, ES (low CI.95, high CI.95), for eliciting changes in response of measure of interest between the various methods of exercise based on the durations of training.
| BM | FM | FFM | BMI | SBP | DBP | VO2 | Insulin | Glu | A1c | OB | Adip | IL-6 | CRP | TNF-α | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Within <8-weeks of training | |||||||||||||||
| ET v. RT | -0.11 | -0.39 | -0.26 | -0.28 | 0.00 | -2.45 | -0.69 | 0.04 | -0.16 | -0.15 | 0.07 | -0.37 | -0.26 | -0.94 | -0.38 |
| ET v. E+R | -0.26 | -0.40 | -0.18 | 0.09 | --- | --- | 0.60 | 0.32 | 0.07 | 0.22 | -0.19 | 0.21 | -0.19 | -0.23 | -0.55 |
| E+R v. RT | 0.02 | -0.03 | -0.08 | -0.21 | --- | --- | -1.26 | -0.23 | -0.17 | -0.30 | 0.20 | -1.02 | 0.22 | -0.55 | 0.21 |
| Within 9-15 weeks of training | |||||||||||||||
| ET v. RT | -0.05 | -0.34 | -0.18 | -0.08 | 0.41 | 0.13 | 0.24 | -0.17 | -0.10 | -0.22 | 0.02 | -0.13 | -0.29 | 0.05 | -1.10 |
| ET v. E+R | -0.12 | -0.19 | -0.25 | -0.07 | -0.73 | 0.24 | 0.41 | -0.15 | 0.09 | 0.06 | --- | -0.20 | 0.04 | 0.02 | 0.23 |
| E+R v. RT | 0.03 | -0.34 | 0.11 | -0.08 | 1.35 | -0.13 | -0.10 | 0.21 | -0.11 | -0.54 | --- | 0.13 | -0.30 | 0.05 | -1.09 |
| Within 16-23 weeks of training | |||||||||||||||
| ET v. RT | 0.07 | 0.23 | 0.02 | 0.04 | 0.25 | 0.13 | 0.23 | 0.63 | 0.38 | 0.11 | --- | -1.06 | --- | -0.50 | --- |
| ET v. E+R | -0.26 | -0.08 | 0.02 | -0.55 | -0.13 | -0.30 | 0.43 | 0.58 | 0.07 | -0.77 | --- | 0.39 | --- | 0.03 | --- |
| E+R v. RT | 0.32 | 0.33 | 0.00 | 0.65 | 0.35 | 0.45 | -0.15 | -0.01 | 0.31 | 0.82 | -1.61 | -0.86 | --- | --- | --- |
| Within 24-36 weeks of training | |||||||||||||||
| ET v. RT | 0.28 | -0.77 | -0.07 | 0.70 | --- | --- | 0.55 | 0.21 | 0.03 | 0.57 | --- | --- | --- | --- | --- |
| ET v. E+R | -0.13 | -0.12 | -0.03 | -0.11 | --- | --- | 0.09 | --- | 0.03 | 0.41 | --- | --- | --- | --- | --- |
| E+R v. RT | 0.49 | -0.72 | -0.04 | 0.67 | 1.00 | 0.41 | 1.09 | --- | -0.01 | 0.15 | --- | --- | --- | --- | --- |
| Within >36-weeks of training | |||||||||||||||
| ET v. RT | -0.33 | -0.21 | -0.44 | -0.54 | 0.58 | 0.48 | 0.00 | -0.09 | 0.07 | -0.48 | --- | --- | --- | --- | --- |
| ET v. E+R | -0.34 | -0.15 | -0.44 | -0.27 | 0.43 | -0.18 | -0.20 | 0.08 | 0.11 | -0.06 | --- | --- | --- | (7.14) | --- |
| E+R v. RT | 0.03 | -0.09 | -0.13 | -0.38 | 0.43 | 0.67 | 0.24 | -0.15 | -0.05 | -0.42 | --- | --- | --- | --- | --- |
Note: Note that comparisons based on endurance versus resistance training methods (El v. RT), endurance versus combination of endurance and resistance training methods (ET v. E+R), combination of endurance and resistance versus resistance training methods (E + R v RT). Negative (-) values indicate favor toward the second exercise group in the comparison between the methods of exercise, while ‘---‘ indicates indicates not enough studies in the group to determine pooled effect size and CI.95.
FIG. 2Indicated pooled ES and CI.95 for effective to elicit responses for altering adipokines (leptin, OB, and adiponectin, Adip) associated with health issues related to overfatness obtained from the various training durations (indicated by @ and then number of weeks of training) for the various modes of exercise. Indication of a positive ES shows favor for the use of intervention, while negative ES shows favor toward not utilizing said intervention. ET indicated by ●, RT indicated by ♦, E+R indicated by ■, and All Ex indicated by ▲.
FIG. 3Indicated pooled ES and CI.95 for effective to elicit responses for altering markers of T2DM, fasting insulin, glucose and A1c levels, associated with overfatness obtained following the various training durations (indicated by @ and then number of weeks of training) for all exercise (ALL Ex) or endurance training ET. Indication of a positive ES shows favor for the use of intervention, while negative ES shows favor toward not utilizing said intervention. Note that ♦ indicates Insulin, ■ indicates glucose and ▲ indicates A1c.
FIG. 4Indicated pooled ES and CI.95 for effectiveness to elicit responses for altering markers of T2DM, fasting insulin, glucose and A1c levels, associated with overfatness elicited within the various training durations (indicated by @ and then number of weeks of training) for resistance training RT or combination of endurance and resistance training E+R. Indication of a positive ES shows favor for the use of intervention, while negative ES shows favor toward not utilizing said intervention. Note that ♦ indicates Insulin, ■ indicates glucose and ▲ indicates A1c.
SUPPLEMENTAL FIG. 3Indicated pooled ES and CI.95 for effective to elicit responses for altering cytokines (C-reactive protein as CRP, interleukin-6 as IL-6 and tumor necrotic factor-α as TNF-α) associated with health issues related to overfatness based on the various training durations (indicated by @ and then number of weeks of training) for the stimulus from the various modes of exercise. Indication of a positive ES shows favor for the use of intervention, while negative ES shows favor toward not utilizing said intervention. ET indicated by ●, RT indicated by ♦, E+R indicated by ■, and All Ex indicated by ▲.